SNDL's transition into a diversified retail and investment conglomerate provides a defensive buffer, yet the company struggles to achieve consistent operating profitability as evidenced by the $11.2M operating loss in 2026Q1. While the firm maintains a robust ...
Price trend, volume and key moving averages
Trailing total returns as of 9/24/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Jul 28, 2026 | -$0.02-468.2% vs -$0.00 | $166M-0.2% vs $166M |
Q2 2026 Apr 29, 2026 | -$0.03+0.0% vs -$0.03 | $141M-6.8% vs $151M |
Q2 2026 Mar 12, 2026 | $0.03+200.0% vs $0.01 | $184M-2.1% vs $188M |
Q4 2025 Nov 4, 2025 | -$0.04 vs -$0.00 | $175M-32.1% vs $258M |
SNDL Inc. (NASDAQ: SNDL - Get Free Report) saw unusually large options trading on Tuesday. Investors acquired 4,741 call options on the stock. This is an increase of approximately 371% compared to the average volume of 1,007 call options. Wall Street Analyst Weigh In Several brokerages have issued reports on SNDL. Weiss Ratings raised shares of
EDMONTON, Alberta, Aug. 04, 2026 (GLOBE NEWSWIRE) -- SNDL Inc. (NASDAQ: SNDL, CSE: SNDL) (“SNDL” or the “Company”) today announced the successful completion of a European Union Good Manufacturing Practice ("EU-GMP") audit at its Atholville, New Brunswick cultivation facility. The successful audit reinforces SNDL's ability to participate in regulated international medical cannabis markets and reflects the Company's continued focus on quality, operational excellence, and regulatory compliance.
Earlier this week, SNDL Inc. SNDL reported dismal second-quarter 2026 results, with earnings and sales missing consensus estimates.
SNDL reported weaker Q2-2026 financial performance earlier this week with lower revenue YoY and a net loss. SNDL completed the restructuring of its US Skymint assets and is well-positioned to enter US THC markets upon rescheduling. The cannabis sector remains weak due to uncertainty; the DEA hearing to reschedule cannabis has no updates.
Benchmark SNDL against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for SNDL Inc. (SNDL)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $1.40 | $364.42M | -32.92 | 2.82% | -1.67% | -1.41% | — | |
| $3.40 | $1.27B | -135.46 | 26.81% | 28.74% | 6.18% | — | |
| $0.94 | $394.99M | -1.50 | 5.8% | -80.67% | -32.79% | — | |
| $4.22 | $261.4M | -2.78 | -6.61% | -38.15% | -20.36% | — | |
| $4.11 | $459.63M | -3.77 | -18.77% | -12.9% | -8.09% | — | |
| $1.09 | $153.44M | -10.99 | 16.42% | 28.02% | 21.02% | — |
SNDL Inc. (SNDL) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Get notified when SNDL posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
SNDL Inc. (SNDL) stock FAQ — growth, dividends, profitability & financials explained
SNDL Inc. (SNDL) reported $928.4M in revenue for fiscal year 2025.
SNDL Inc. (SNDL) grew revenue by 2.8% over the past year. Growth has been modest.
SNDL Inc. (SNDL) reported a net loss of $21.7M for fiscal year 2025.
SNDL Inc. (SNDL) has a return on equity (ROE) of -1.4%. Negative ROE indicates the company is unprofitable.
SNDL Inc. (SNDL) generated $50.6M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
